Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
The independent source for health policy research, polling, and news.
101 - 110 of 110 Results
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.
As states struggle to respond to the national drug crisis, officials around the country are watching Oklahoma. The state's attorney general says opioid drugmakers helped ignite a health crisis that has killed thousands of residents.
Ohio is the latest Republican-led state to pass a ban on abortion once a fetal heartbeat can be detected. But Tennessee last week backed off on a similar bill, fearing costly legal battles. What now?
Health officials and doctors treating patients with HIV welcome the funding push, but warn that the strategies that work in progressive cities don't necessarily translate to rural areas.
Medicaid drug spending doubled in five years in Massachusetts. The state wanted to exclude expensive drugs that weren't proven to work better than existing alternatives from its Medicaid plan, but the federal government blocked the effort.
The Trump administration has talked about prioritizing the opioid crisis, but states have seen little in the way of new resources. And, in some states, getting into treatment is becoming even harder.
In a letter to all governors, HHS Secretary Tom Price invited them to consider seeking federal help to set up reinsurance funds that would help cover losses that insurers have because of high numbers of sick patients.
Florida and Oklahoma counties are among the hardest hit by UnitedHealthcare's pullout from health law exchanges.
UnitedHealthcare said Tuesday it will leave most of the 34 states in which it offers health insurance under Obamacare, but Nevada and Virginia are two markets it will retain a presence.
© 2026 KFF